Lb Pharmaceuticals LBRX
NASDAQ LBRX
$39.23 -1.77 (-4.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Non-Current Assets (2024 - 2026)

Updated

Lb Pharmaceuticals' Non-Current Assets was $6.39 million in Q2 2026, up 45.0% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Lb Pharmaceuticals came in at $4.5 million, down 3.3% from FY2024.

  • In earlier years, Non-Current Assets was $4.66 million in FY2024.
  • Per Business Quant data, LBRX's Non-Current Assets in the three quarters before Q2 2026 was $4.41 million (Q1 2026), $4.5 million (Q4 2025) and $4.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Lb Pharmaceuticals 1.18 Bn -123.53 Mn - 6.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.39 Mn
Mar 31, 2026 4.41 Mn
Dec 31, 2025 4.50 Mn
Sep 30, 2025 4.35 Mn
Dec 31, 2024 4.66 Mn
API Access

Lb Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=LBRX&period=max&api_key=YOUR_API_KEY